Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo third-quarter sales up 13% to $185.3 mil.; soft analgesic sales lead to income drop.

This article was originally published in The Tan Sheet

Executive Summary

PERRIGO THIRD-QUARTER SALES RISE 13% TO $185.3 MIL., boosted by a more than 20% increase in cough/cold products. The over 20% gain was generated by a "stronger end" to the cough and cold season, the company said in a May 9 release. However, net income was down 13.9% to $11.4 mil. in the quarter from $13.3 mil. in the comparable period of fiscal 1994
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083832

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel